# US 2001/0024799 A1 · Method and apparatus for detecting conception in animals

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0024799 A1
- Document ID: US20010024799A1
- Status: Published application
- Kind: A1
- Application number: 09/764,826
- Filed: 2001-01-17
- Published: 2001-09-27
- Earliest claimed: 1998-02-02
- Assignees: Concepto Diagnostics, Inc.
- Inventors: Nancy Tommye Jordan; John Douglas Jordan
- Web page: https://patentgrep.com/patent/US20010024799A1

## CPC

- G01N 33/689: {related to pregnancy or the gonads}
- C07K 16/18: against material from animals or humans
- G01N 2800/368: Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
- Y10S 436/814: Pregnancy
- Y10S 436/815: Test for named compound or class of compounds
- Y10S 436/817: Steroids or hormones
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

The present invention provides antibodies which specifically bind early conception factor, which can be found in body fluids of animals including but not limited to the cow, cat, dog, horse, human, sheep, and pig. The invention provides methods for detecting conception or the absence of conception in an animal, the latter being recognized by the absence of early conception factor in a suitable body fluid collected from the animal. Apparati for detecting early conception factor in a body fluid from an animal comprising the antibodies which specifically bind early conception factor are also provided.

## Claims

### Claim 1

An isolated antibody which specifically binds purified early conception factor.

### Claim 2

An isolated antibody which specifically binds purified early conception factor which has a molecular weight of approximately 200,000.

### Claim 3 (depends on 2)

An isolated antibody of claim 2 wherein the early conception factor is from a species selected from the group consisting of cow, cat, dog, horse, human, sheep, and pig.

### Claim 4 (depends on 1, 2, 3)

An antibody according to any one of claims 1, 2 or 3 wherein said antibody is selected from the group consisting of polyclonal, monoclonal, humanized, fully human, or chimeric antibodies.

### Claim 5

A method for detecting conception in an animal comprising detecting the presence of early conception factor in a body fluid of the animal.

### Claim 6 (depends on 5)

The method of claim 5, wherein the body fluid is serum.

### Claim 7 (depends on 5)

The method of claim 5, wherein the body fluid is urine.

### Claim 8 (depends on 5)

The method of claim 5, wherein the body fluid is milk.

### Claim 9

A method for determining the absence of conception in a cow within the first twelve hours of gestation comprising determining the presence or absence of early conception factor, the absence of early conception factor indicating the absence of conception.

### Claim 10

A method for determining the absence of conception in a cow within the first twenty-four hours of gestation comprising determining the presence or absence of early conception factor, the absence of early conception factor indicating the absence of conception.

### Claim 11

A method for detecting early conception factor in an animal comprising the steps of:
a. collecting a sample from the animal;
b. contacting the sample with anti-(early conception factor) antibodies under conditions whereby the antibodies can bind early conception factor protein present in the sample; and
c. detecting the antibody-early conception factor complexes.

### Claim 12 (depends on 11)

The method of claim 11 wherein the sample is selected from the group consisting of serum, urine and milk.

### Claim 13 (depends on 11)

The method of claim 11 wherein the anti-early conception factor antibody is conjugated to a detectable moiety, and the antibody-early conception factor complex is detected by adding a substrate or inducer, and monitoring detectable changes in the receptacle.

### Claim 14 (depends on 13)

The method of claim 13 wherein the anti-(early conception factor) antibodies are conjugated to a moiety selected from the group consisting of alkaline phosphatase, horseradish peroxidase, colloidal gold, and urease.

### Claim 15

An apparatus for detecting early conception factor in a fluid containing a sample from a subject, comprising:
a. a body portion; and
b. a support, having thereon an antibody to early conception factor, in contact with the body portion.

### Claim 16 (depends on 15)

The apparatus of claim 15, wherein the support comprises a material that wicks a fluid.

### Claim 17 (depends on 15)

The apparatus of claim 15, wherein the antibody is conjugated to a detectable moiety.

### Claim 18 (depends on 15)

The apparatus of claim 15, wherein the substrate has both a monoclonal and a polyclonal anti-(early conception factor) antibody thereon.

### Claim 19 (depends on 18)

The apparatus of claim 18, wherein the monoclonal and polyclonal anti-(early conception factor) antibodies are spacially separated on the support.

### Claim 20 (depends on 18)

The apparatus of claim 18, wherein the polyclonal antibody is localized in a band, wherein the band is substantially perpendicular to the longitudinal axis of the support.

### Claim 21 (depends on 18)

The apparatus of claim 18, further comprising a means on the body portion for directing a fluid to the support.

### Claim 22 (depends on 21)

The apparatus of claim 21, wherein the means on the body portion for directing a fluid to the support, directs the fluid to a location on the support whereon the monoclonal antibody is located, whereby the sample contacts the monoclonal antibody and the support wicks the monoclonal antibody and the fluid into contact with the band containing the polyclonal antibody.
